Abbott

Stories

FDA clears Abbott's dual-energy ablation catheter for complex AFib

Expanding U.S. and global ablation portfolio

The Food and Drug Administration cleared Abbott's TactiFlex Duo, the first U.S. ablation catheter to combine pulsed field and radiofrequency energy. The device is designed for complex atrial fibrillation, a condition affecting about 10.5 million Americans.

Updated Yesterday

Medtronic wins first FDA approval for a defibrillation lead that paces through the heart's natural wiring

New Capabilities

Pursuing leadless conduction system pacing (investigational)

For decades, defibrillators have saved lives by shocking dangerously fast rhythms back to normal, but the leads also pace the heart unnaturally and can cause damage over time. Medtronic's OmniaSecure lead is the first defibrillation lead that can pace through the heart's own electrical wiring, closely mimicking natural heartbeats. It has been cleared by the FDA for placement in the left bundle branch area.

Updated May 30